...Savara acquired fellow pulmonary company Serendex in a stock deal. Savara will gain Molgradex , a...
...Denmark) granted Serendex exclusive, worldwide rights to develop and commercialize Factor VIIa for pulmonary administration. Serendex...
...approval of Molgradex and Factor VIIa in Europe and Japan (see BioCentury, Feb. 16, 2015). Serendex Pharmaceuticals A/S...

...CMC granted Serendex exclusive, worldwide rights to develop and commercialize Factor VIIa for pulmonary administration. Serendex...
...next year. The companies declined to disclose financial details. CMC Biologics A/S , Copenhagen, Denmark Serendex Pharmaceuticals A/S...